Salugan, Nina H.
HRN: 26-48-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2026
CEFIXIME 200MG (CAP)
07/14/2026
07/21/2026
PO
200mg Tab
Bid
Skin And Soft Tissue Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes